Article
Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
CNS neuroscience & therapeutics - 1 Dec 2018
Feng Jie, Wang Jing-Xue, Du Ye-Hong, Liu Ying, Zhang Wei, Chen Jing-Fei, Liu Yuan-Jie, Zheng Min, Wang Ke-Jian, He Gui-Qiong
Abstract excerpt
BACKGROUND: Activated microglia-mediated inflammation plays a key role in the pathogenesis of Alzheimer's disease (AD). In addition, chronic activation of NLRP3 inflammasomes triggered by amyloid β peptide (Aβ) in microglia contributes to persistent neuroinflammation. Here, the primary goal was to assess whether Dihydromyricetin (DHM), a plant flavonoid compound, is effective therapies for AD; it is crucial to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
